Clorindione
Chemical compound
- B01AA09 (WHO)
- 2-(4-chlorophenyl)-1H-indene-1,3(2H)-dione
- 1146-99-2
- 70846
- 64010
Y
- 541C7WS64R
- D07135 Y
- ChEMBL278519 Y
- DTXSID0046228
- Interactive image
- Clc1ccc(cc1)C3C(=O)c2ccccc2C3=O
InChI
- InChI=1S/C15H9ClO2/c16-10-7-5-9(6-8-10)13-14(17)11-3-1-2-4-12(11)15(13)18/h1-8,13HY
- Key:NJDUWAXIURWWLN-UHFFFAOYSA-NY
Clorindione is a vitamin K antagonist.[1] It is a derivative of phenindione.[citation needed]
References
- ^ Shurrab M, Quinn KL, Kitchlu A, Jackevicius CA, Ko DT (September 2019). "Long-Term Vitamin K Antagonists and Cancer Risk: A Systematic Review and Meta-Analysis". American Journal of Clinical Oncology. 42 (9): 717–724. doi:10.1097/COC.0000000000000571. PMID 31313676. S2CID 197421591.
Further reading
- Elks J, Ganellin CR (14 November 2014). The Dictionary of Drugs: Chemical Data. Springer-Science + Business Media, BV. p. 257. ISBN 978-1-4757-2085-3.[full citation needed]
- v
- t
- e
Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01)
| Glycoprotein IIb/IIIa inhibitors |
|
|---|---|
| ADP receptor/P2Y12 inhibitors | |
| Prostaglandin analogue (PGI2) | |
| COX inhibitors | |
| Thromboxane inhibitors | |
| Phosphodiesterase inhibitors | |
| Other |
| Vitamin K antagonists (inhibit II, VII, IX, X) | |||||
|---|---|---|---|---|---|
| Factor Xa inhibitors (with some II inhibition) |
| ||||
| Direct thrombin (IIa) inhibitors |
| ||||
| Other |
fibrinolytics
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
